Your session is about to expire
← Back to Search
Intermittent Fasting for Crohn's Disease
Study Summary
This trial is investigating whether an Intermittent Calorie Reduced Diet that mimics fasting could help treat Crohn's disease by reducing inflammation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I do not have severe heart disease, such as bad heart failure or a weak heart pump.My Crohn's disease is in the mild to moderate stage.I am severely weakened by a disease or medical procedure.I am not pregnant, nursing, or planning to become pregnant.I have a serious medical condition approved by my doctor.I have diabetes and am on medication that could lower my blood sugar too much.You have severe heart problems or advanced cancer, unless a doctor approves your participation.I have not had major GI surgery affecting my digestion significantly.You have specific dietary needs that cannot be accommodated by the meal plan provided in the study.You have a nut allergy.You have a history of fainting or passing out.Your body weight is too low for this study, based on a measurement called BMI.I am between 18 and 70 years old.I have liver or kidney issues that could worsen with a low sugar and protein diet.I am on medication that is unsafe with a low-calorie diet.
- Group 1: Intervention Arm
- Group 2: Control Arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What criteria must a person meet to be eligible for this clinical trial?
"Currently, 75 individuals aged 18 to 70 who have been diagnosed with ileocolitis are being recruited for this clinical trial. Eligibility is contingent on demonstrating mild to moderate Crohn's disease (CDAI score 151-450)."
Does this inquiry accept individuals aged eighty-five and above?
"According to the official enrollment requirements, patients must be between 18 and 70 years old to qualify for this clinical trial."
Is there presently an opportunity to join this research endeavor?
"Affirmative. According to clinicaltrials.gov, this research project is still in recruitment mode since it was first published on December 18th 2019 and last modified on August 26th 2022. Currently the study requires 75 volunteers from a single site."
How many participants are being recruited for this trial?
"Affirmative. According to clinicaltrials.gov, this trial which was initially posted on December 18th 2019 is currently recruiting participants. 75 individuals are needed from a single medical site."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger